| Mepha Pharma AG - Celecoxib-Mepha Teva 200 mg, Hartkapseln | | 69355 | | 02 | | Celecoxib-Mepha Teva 200 mg | | Hartkapseln | | M01AH01 | | Celecoxib | | 06.05.2025 | | |
| | Composition | | celecoxibum 200 mg, natrii laurilsulfas, lactosum monohydricum 48.4 mg, crospovidonum, povidonum K 29-32, magnesii stearas, Kapselhülle: gelatina, aqua purificata, E 171, natrii laurilsulfas, Drucktinte: lacca, E 172 (flavum), pro capsula corresp. natrium 0.435 mg. | | Packungsbestandteile | | Capsules | | | | | | Principe actif | Concentr. |
|---|
| Célécoxib | 200 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Aqua Purificata | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Lactose Monohydrate | 48.4 mg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 29-32 | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 | DDP | DDP | B | | Non | | 003 | 100 | DDP | DDP | B | | Non |
|
|
